Article info
PDFOriginal Article
Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study)
- R Jorge, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Avenida Bandeirantes 3900. Ribeirão Preto-SP 14049-900, Brazil; rjorge{at}fmrp.usp.br
Citation
Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study)
Publication history
- Accepted September 11, 2007
- First published October 26, 2007.
Online issue publication
December 21, 2007
Article Versions
- Previous version (26 October 2007).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group